Gender differences in perinatal HIV acquisition among African infants

Taha E Taha, Samah Nour, Newton I. Kumwenda, Robin L. Broadhead, Susan A. Fiscus, George Kafulafula, Chiwawa Nkhoma, Shu Chen, Donald R. Hoover

Research output: Contribution to journalArticle

Abstract

Objective. We investigated gender-specific risks of mother-to-child transmission (MTCT) at birth and at 6 to 8 weeks among infants born to HIVinfected African women. Design. Follow-up study of infants enrolled in 2 randomized, phase III, clinical trials to prevent MTCT, conducted in Blantyre, Malawi, in southeast Africa. Methods. Infants were enrolled at birth and monitored postnatally, and their HIV status was assessed at birth and at 6 to 8 weeks (assessment beyond 6-8 weeks is ongoing). Statistical analyses were stratified according to gender, and comparisons were made with descriptive, univariate, and multivariate statistical tests. MTCT was estimated at birth and at 6 to 8 weeks among infants who were not infected at birth. Results. Overall, 966 boys and 998 girls were enrolled. The rate of HIV transmission at birth was 9.5% (187 of 1964 infants). However, at birth significantly more girls (12.6%) than boys (6.3%) were infected with HIV. This association remained significant after controlling for maternal viral load and other factors. Among infants who were uninfected at birth, 8.7% (135 of 1554 infants) acquired HIV by 6 to 8 weeks; of these infants, more girls acquired HIV (10.0%), compared with boys (7.4%). Conclusions. Female infants may be more susceptible to HIV infection before birth and continuing after birth. Alternatively, in utero mortality rates of HIV-infected male infants may be disproportionately higher and thus more HIV-infected female infants are born. In areas of sub-Saharan Africa, where HIV infection rates are high among women of reproductive age, the magnitude of the gender transmission differences observed in this study could have clinical, preventive, and demographic implications.

Original languageEnglish (US)
JournalPediatrics
Volume115
Issue number2
DOIs
StatePublished - Feb 2005

Fingerprint

HIV
Parturition
Mothers
HIV Infections
Malawi
Phase III Clinical Trials
Africa South of the Sahara
Viral Load
Demography
Mortality

Keywords

  • Acquisition
  • Africa
  • Gender
  • HIV
  • Mother-to-child transmission
  • Susceptibility

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Taha, T. E., Nour, S., Kumwenda, N. I., Broadhead, R. L., Fiscus, S. A., Kafulafula, G., ... Hoover, D. R. (2005). Gender differences in perinatal HIV acquisition among African infants. Pediatrics, 115(2). https://doi.org/10.1542/peds.2004-1590

Gender differences in perinatal HIV acquisition among African infants. / Taha, Taha E; Nour, Samah; Kumwenda, Newton I.; Broadhead, Robin L.; Fiscus, Susan A.; Kafulafula, George; Nkhoma, Chiwawa; Chen, Shu; Hoover, Donald R.

In: Pediatrics, Vol. 115, No. 2, 02.2005.

Research output: Contribution to journalArticle

Taha, TE, Nour, S, Kumwenda, NI, Broadhead, RL, Fiscus, SA, Kafulafula, G, Nkhoma, C, Chen, S & Hoover, DR 2005, 'Gender differences in perinatal HIV acquisition among African infants', Pediatrics, vol. 115, no. 2. https://doi.org/10.1542/peds.2004-1590
Taha TE, Nour S, Kumwenda NI, Broadhead RL, Fiscus SA, Kafulafula G et al. Gender differences in perinatal HIV acquisition among African infants. Pediatrics. 2005 Feb;115(2). https://doi.org/10.1542/peds.2004-1590
Taha, Taha E ; Nour, Samah ; Kumwenda, Newton I. ; Broadhead, Robin L. ; Fiscus, Susan A. ; Kafulafula, George ; Nkhoma, Chiwawa ; Chen, Shu ; Hoover, Donald R. / Gender differences in perinatal HIV acquisition among African infants. In: Pediatrics. 2005 ; Vol. 115, No. 2.
@article{25eca13d7a6741d0bdf30ba88eae68d3,
title = "Gender differences in perinatal HIV acquisition among African infants",
abstract = "Objective. We investigated gender-specific risks of mother-to-child transmission (MTCT) at birth and at 6 to 8 weeks among infants born to HIVinfected African women. Design. Follow-up study of infants enrolled in 2 randomized, phase III, clinical trials to prevent MTCT, conducted in Blantyre, Malawi, in southeast Africa. Methods. Infants were enrolled at birth and monitored postnatally, and their HIV status was assessed at birth and at 6 to 8 weeks (assessment beyond 6-8 weeks is ongoing). Statistical analyses were stratified according to gender, and comparisons were made with descriptive, univariate, and multivariate statistical tests. MTCT was estimated at birth and at 6 to 8 weeks among infants who were not infected at birth. Results. Overall, 966 boys and 998 girls were enrolled. The rate of HIV transmission at birth was 9.5{\%} (187 of 1964 infants). However, at birth significantly more girls (12.6{\%}) than boys (6.3{\%}) were infected with HIV. This association remained significant after controlling for maternal viral load and other factors. Among infants who were uninfected at birth, 8.7{\%} (135 of 1554 infants) acquired HIV by 6 to 8 weeks; of these infants, more girls acquired HIV (10.0{\%}), compared with boys (7.4{\%}). Conclusions. Female infants may be more susceptible to HIV infection before birth and continuing after birth. Alternatively, in utero mortality rates of HIV-infected male infants may be disproportionately higher and thus more HIV-infected female infants are born. In areas of sub-Saharan Africa, where HIV infection rates are high among women of reproductive age, the magnitude of the gender transmission differences observed in this study could have clinical, preventive, and demographic implications.",
keywords = "Acquisition, Africa, Gender, HIV, Mother-to-child transmission, Susceptibility",
author = "Taha, {Taha E} and Samah Nour and Kumwenda, {Newton I.} and Broadhead, {Robin L.} and Fiscus, {Susan A.} and George Kafulafula and Chiwawa Nkhoma and Shu Chen and Hoover, {Donald R.}",
year = "2005",
month = "2",
doi = "10.1542/peds.2004-1590",
language = "English (US)",
volume = "115",
journal = "Pediatrics",
issn = "0031-4005",
publisher = "American Academy of Pediatrics",
number = "2",

}

TY - JOUR

T1 - Gender differences in perinatal HIV acquisition among African infants

AU - Taha, Taha E

AU - Nour, Samah

AU - Kumwenda, Newton I.

AU - Broadhead, Robin L.

AU - Fiscus, Susan A.

AU - Kafulafula, George

AU - Nkhoma, Chiwawa

AU - Chen, Shu

AU - Hoover, Donald R.

PY - 2005/2

Y1 - 2005/2

N2 - Objective. We investigated gender-specific risks of mother-to-child transmission (MTCT) at birth and at 6 to 8 weeks among infants born to HIVinfected African women. Design. Follow-up study of infants enrolled in 2 randomized, phase III, clinical trials to prevent MTCT, conducted in Blantyre, Malawi, in southeast Africa. Methods. Infants were enrolled at birth and monitored postnatally, and their HIV status was assessed at birth and at 6 to 8 weeks (assessment beyond 6-8 weeks is ongoing). Statistical analyses were stratified according to gender, and comparisons were made with descriptive, univariate, and multivariate statistical tests. MTCT was estimated at birth and at 6 to 8 weeks among infants who were not infected at birth. Results. Overall, 966 boys and 998 girls were enrolled. The rate of HIV transmission at birth was 9.5% (187 of 1964 infants). However, at birth significantly more girls (12.6%) than boys (6.3%) were infected with HIV. This association remained significant after controlling for maternal viral load and other factors. Among infants who were uninfected at birth, 8.7% (135 of 1554 infants) acquired HIV by 6 to 8 weeks; of these infants, more girls acquired HIV (10.0%), compared with boys (7.4%). Conclusions. Female infants may be more susceptible to HIV infection before birth and continuing after birth. Alternatively, in utero mortality rates of HIV-infected male infants may be disproportionately higher and thus more HIV-infected female infants are born. In areas of sub-Saharan Africa, where HIV infection rates are high among women of reproductive age, the magnitude of the gender transmission differences observed in this study could have clinical, preventive, and demographic implications.

AB - Objective. We investigated gender-specific risks of mother-to-child transmission (MTCT) at birth and at 6 to 8 weeks among infants born to HIVinfected African women. Design. Follow-up study of infants enrolled in 2 randomized, phase III, clinical trials to prevent MTCT, conducted in Blantyre, Malawi, in southeast Africa. Methods. Infants were enrolled at birth and monitored postnatally, and their HIV status was assessed at birth and at 6 to 8 weeks (assessment beyond 6-8 weeks is ongoing). Statistical analyses were stratified according to gender, and comparisons were made with descriptive, univariate, and multivariate statistical tests. MTCT was estimated at birth and at 6 to 8 weeks among infants who were not infected at birth. Results. Overall, 966 boys and 998 girls were enrolled. The rate of HIV transmission at birth was 9.5% (187 of 1964 infants). However, at birth significantly more girls (12.6%) than boys (6.3%) were infected with HIV. This association remained significant after controlling for maternal viral load and other factors. Among infants who were uninfected at birth, 8.7% (135 of 1554 infants) acquired HIV by 6 to 8 weeks; of these infants, more girls acquired HIV (10.0%), compared with boys (7.4%). Conclusions. Female infants may be more susceptible to HIV infection before birth and continuing after birth. Alternatively, in utero mortality rates of HIV-infected male infants may be disproportionately higher and thus more HIV-infected female infants are born. In areas of sub-Saharan Africa, where HIV infection rates are high among women of reproductive age, the magnitude of the gender transmission differences observed in this study could have clinical, preventive, and demographic implications.

KW - Acquisition

KW - Africa

KW - Gender

KW - HIV

KW - Mother-to-child transmission

KW - Susceptibility

UR - http://www.scopus.com/inward/record.url?scp=17844405335&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=17844405335&partnerID=8YFLogxK

U2 - 10.1542/peds.2004-1590

DO - 10.1542/peds.2004-1590

M3 - Article

C2 - 15687425

AN - SCOPUS:17844405335

VL - 115

JO - Pediatrics

JF - Pediatrics

SN - 0031-4005

IS - 2

ER -